PharmaEssentia Announces Major Financial Information Due to Securities Trading Alert on Taiwan Exchange

1. Date of Event: July 8, 115 (2026)

2. Reason for Disclosure: In accordance with notification from the Taiwan Stock Exchange Corporation.

3. Financial and Business Information:

Period (Monthly) (Quarterly) (Last Four Quarters Cumulative) (IFRS - Consolidated Self-Compilation) (IFRS - Consolidated Reviewed) (IFRS - Consolidated Audited/Reviewed) ------------------------------------------------------------------------------------------------------------------------ Most Recent Month YoY Change % Most Recent Quarter YoY Change % (Q2 114 to Q1 115) Item (May 115) (Q1 115) ------------------------------------------------------------------------------------------------------------------------ Operating Revenue 2,458 108.48 5,121 57.23 17,499 (Million) Pre-tax Net Profit 1,291 -389.46(Note) 2,336 60.00 5,859 (Million) Net Profit Attributable to Owners of Parent 993 -337.56(Note) 2,150 70.23 5,932 (Million) Earnings Per Share (EPS) 2.66 -335.40(Note) 5.79 69.30 16.02 (NT$)

Note: The year-on-year comparison is negative because the same period last year was a loss.

4. Whether there are any material events under Article 4 of the 'Taiwan Stock Exchange Corporation Procedures for Verification and Public Disclosure of Material Information by Listed Companies': No.

5. Whether there is a requirement to hold a press conference under Article 11 of the same procedures: No.

6. Complete financial information is available on the Public Information Observation Station. Access paths: (1) Recent operating revenue and profit/loss: Basic Information > Summary Version (2) Historical monthly revenue: Operations Overview > Monthly Revenue > Monthly Operating Revenue Information (Post-IFRS Adoption) (3) Historical profit/loss (audited/reviewed by CPAs): Financial Statements > Post-IFRS Adoption > Consolidated/Individual Statements > Consolidated Statement of Comprehensive Income (4) Historical profit/loss (voluntary self-compiled announcements): Operations Overview > Self-Compiled Earnings Announcements

7. Other Matters to be Disclosed: None.